Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients-Reference-Cited by-同舟云学术

Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients

Published:2009-06-19 Issue:2 Volume:183 Page:841-848
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Luther Claudia,Adamopoulou Eleni,Stoeckle Christina,Brucklacher-Waldert Verena,Rosenkranz Daniela,Stoltze Lars,Lauer Sigrid,Poeschel Simone,Melms Arthur,Tolosa Eva

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Autoreactive T Cells in Healthy Individuals

2. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

3. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood

4. Control of Regulatory T Cell Development by the Transcription Factor Foxp3

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic gene expression analysis reveals a potential link between HIF-1A and Th17/Treg imbalance in thymoma associated myasthenia gravis;Journal of Neuroinflammation;2024-05-11

2. Vaccine development: Current trends and technologies;Life Sciences;2024-01

3. Effect of thymectomy on the frequencies of peripheral regulatory B and T lymphocytes in patients with Myasthenia gravis-a pilot study;International Journal of Neuroscience;2023-09-09

4. Long-term efficacy and safety of leflunomide combined with low-dose prednisone in treatment of myasthenia gravis: a retrospective study;Acta Neurologica Belgica;2023-09-01

5. Serum Omega-3 Fatty Acids Impair Regulatory T Cell Suppressive Function and are Potential Pathogenic Factors of Myasthenia Gravis;2023